RSPCA encouraged that the import of animal medicines will be prioritised post-Brexit

12 March 2019, at 2:16pm

The RSPCA welcomes the decision of the UK government to prioritise animal medicine imports in the event of a no-deal Brexit.

RSPCA Chief Veterinary Officer Caroline Allen said: “We are encouraged that the import of animal medicines will be prioritised in the event of a no-deal Brexit.

“We have been very concerned that there could be interruptions to the supply chain of drug supplies used in our veterinary hospitals and other vets if we leave the EU without a trade deal. So we have been urging the government to prioritise the welfare and health of those animals most in need.

“Brexit is likely to have far reaching implications for all aspects of animal welfare as we have seen through the Sentience Bill and changes to the Common Agricultural Policy. But we believe the Government’s decision to add veterinary medicines to the ‘critical goods’ list of items considered essential for the preservation of human and animal welfare is a small step in the right direction to mitigate the negative effects a no-deal Brexit could have on animal welfare.

“However, the devil will be in the detail. The RSPCA remains concerned that veterinary surgeons, unlike veterinary drugs, have not be added to the critical list, and any shortage will greatly impact on animal welfare especially in the slaughter of farm animals. It’s important that welfare, rather than economics, is put first and that the medicines apply to all types of animals, both large and small."

The full policy paper can be read here.